Performance of disc diffusion and gradient strip test on different Mueller–Hinton agar media plates and ComASP® and Bruker UMIC® Cefiderocol Microdilution Panels for cefiderocol susceptibility testing in carbapenem-resistant <i>Pseudomonas aeruginosa

Background Cefiderocol antimicrobial susceptibility testing requires standardized iron levels to produce consistent results. Here we assessed the analytical performances of two commercialized broth microdilution (BMD) methods (Bruker’s UMIC and Liofilchem’s ComASP), of disc diffusion (DD) and the gradient strip method on a collection of clinical carbapenem-resistant-Pseudomonas aeruginosa (CRPA) isolates. Methods A collection of 117 WGS-CRPA was used. Cefiderocol susceptibility was determined (i) by manual BMD (reference method) using iron-depleted Mueller–Hinton (ID-MH), (ii) with the UMIC and ComASP BMD panels, (iii) by DD and (iv) using the gradient strip test, these latter two on bioMérieux MH-agar, Liofilchem MH-agar, and in-house-produced iron-depleted (ID)-MH agar plates. Results Cefiderocol MIC50 and MIC90 were 1 and 4 mg/L, respectively. Eighteen isolates (15.4%) were classified as resistant (MIC &gt; 2 mg/L) according to the standard EUCAST-based BMD. Overall, the ComASP panel showed the highest essential agreement (EA) with the standard BMD (82.1%), with a bias of −8.5%, and categorical agreement (CA) of 94%. The UMIC panel exhibited an EA of 74.4%, with a bias of 47%, and CA of 78.6%, exhibiting a tendency to overestimate the MICs. The EAs of the gradient strip test on bioMérieux-MH, Liofilchem-MH and ID-MH agar plates were 40.2%, 45.3% and 63.2%, respectively. Considering only categorizable results, the CAs of DD were 92.7%, 94.4% and 93.9%, respectively. Conclusions The commercial ComASP panel may be used for cefiderocol testing of P. aeruginosa clinical isolates in diagnostic laboratories, ideally in combination with another method, such as the EUCAST-based DD. However, the standard manual BMD should still be performed to confirm the result when MICs are close to the breakpoint.

Authors

Publication Details

Journal
Universität Zürich, ZORA
Published
2025-10-01
DOI
https://doi.org/10.5167/uzh-293065
Primary Topic
Antibiotics Pharmacokinetics and Efficacy
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Performance of disc diffusion and gradient strip test on different Mueller–Hinton agar media plates and ComASP® and Bruker UMIC® Cefiderocol Microdilution Panels for cefiderocol susceptibility testing in carbapenem-resistant Pseudomonas aeruginosa

Oliver Nolte, Mélanie Mermod, Tim Roloff, Helena M B Seth-Smith et al.
Universität Zürich, ZORA
Antibiotics Pharmacokinetics and Efficacy
article

Performance of disc diffusion and gradient strip test on different Mueller–Hinton agar media plates and ComASP® and Bruker UMIC® Cefiderocol Microdilution Panels for cefiderocol susceptibility testing in carbapenem-resistant Pseudomonas aeruginosa

Oliver Nolte, Mélanie Mermod, Tim Roloff, Helena M B Seth-Smith, Stefano Mancini, Natalia Kolesnik-Goldmann, Adrian Egli, Vladimira Hinic, Muhammad Ali Syed, Irfan Ullah
article en

Abstract

Background Cefiderocol antimicrobial susceptibility testing requires standardized iron levels to produce consistent results. Here we assessed the analytical performances of two commercialized broth microdilution (BMD) methods (Bruker’s UMIC and Liofilchem’s ComASP), of disc diffusion (DD) and the gradient strip method on a collection of clinical carbapenem-resistant-Pseudomonas aeruginosa (CRPA) isolates. Methods A collection of 117 WGS-CRPA was used. Cefiderocol susceptibility was determined (i) by manual BMD (reference method) using iron-depleted Mueller–Hinton (ID-MH), (ii) with the UMIC and ComASP BMD panels, (iii) by DD and (iv) using the gradient strip test, these latter two on bioMérieux MH-agar, Liofilchem MH-agar, and in-house-produced iron-depleted (ID)-MH agar plates. Results Cefiderocol MIC50 and MIC90 were 1 and 4 mg/L, respectively. Eighteen isolates (15.4%) were classified as resistant (MIC &gt; 2 mg/L) according to the standard EUCAST-based BMD. Overall, the ComASP panel showed the highest essential agreement (EA) with the standard BMD (82.1%), with a bias of −8.5%, and categorical agreement (CA) of 94%. The UMIC panel exhibited an EA of 74.4%, with a bias of 47%, and CA of 78.6%, exhibiting a tendency to overestimate the MICs. The EAs of the gradient strip test on bioMérieux-MH, Liofilchem-MH and ID-MH agar plates were 40.2%, 45.3% and 63.2%, respectively. Considering only categorizable results, the CAs of DD were 92.7%, 94.4% and 93.9%, respectively. Conclusions The commercial ComASP panel may be used for cefiderocol testing of P. aeruginosa clinical isolates in diagnostic laboratories, ideally in combination with another method, such as the EUCAST-based DD. However, the standard manual BMD should still be performed to confirm the result when MICs are close to the breakpoint.

Universität Zürich, ZORA
Openalex Percentile: Top 25%
Antibiotics Pharmacokinetics and Efficacy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.